Strata Critical Medical (SRTA) Non-Current Assets (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Non-Current Assets data on file, last reported at $203.5 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $203.5 million, up 107.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $716.8 million (up 77.96% YoY), and the FY2025 annual result was $199.3 million, up 107.73% from the prior year.
• Non-Current Assets improved to $203.5 million in Q1 2026 per SRTA's latest filing, from $199.3 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $212.6 million in Q3 2025 and troughed at $41.4 million in Q1 2022.
• A 5-year average of $113.3 million and a median of $101.4 million in 2025 frame the typical range for Non-Current Assets.
• On a YoY basis, Non-Current Assets climbed as much as 1243.92% in 2022 and fell as far as 85.13% in 2022.
• A 5-year view of Non-Current Assets shows it stood at $106.9 million in 2022, then decreased by 17.05% to $88.7 million in 2023, then grew by 8.18% to $95.9 million in 2024, then surged by 107.73% to $199.3 million in 2025, then rose by 2.1% to $203.5 million in 2026.
• Business Quant data shows SRTA's Non-Current Assets at $203.5 million in Q1 2026, $199.3 million in Q4 2025, and $212.6 million in Q3 2025.